Industry has shown it can overcome challenges en route to creating new therapies.
Marc Helberg
Advertisement
Managing Vice President at the Philadelphia Office of Pariveda
Articles by Marc Helberg
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Caplyta for Prevention of Schizophrenia in Adults
2
Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics
3
How Can Pharma Prices be Reduced for Americans Without Impacting Innovation?
4
Asembia's AXS26 Summit: How US Regulatory Updates are Impacting Global Launch Strategies
5